In recent years, peptide and oligonucleotide therapies have revolutionized modern medicine by offering highly targeted treatment options for a variety of complex diseases. Peptide drugs, composed of short chains of amino acids, interact with specific receptors or enzymes in the body, providing unparalleled precision and reducing the risk of side effects. Their applications span areas such as cancer, metabolic disorders, and neurological conditions, making them a key focus in pharmaceutical innovation.